Company / Book Value per Share
Kura Oncology, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.226
FY2025
5-year range
$2.226 / $7.635
FY2021-FY2025
Trend
-60.0%
vs FY2024
Sector context
#146 of 209
Health Care
What the data says
At $2.226, Kura Oncology, Inc.'s book value per share ranks #146 of 209 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $2.226 in FY2025 to $11.51 in FY2020.
Based on SEC 10-K filings.
$2.226 in FY2025 with a 5-year CAGR of -28.0%.
Declined from $5.425 to $2.226 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -29.2%
- 5-Year CAGR
- -28.0%
- 10-Year CAGR
- -
Sector benchmark
#146 of 209 in Health CareTop 70% of 209This company $2.226 Sector average $189.406
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -28.0%, indicating a declining trend.
- In FY2025, book value per share decreased 60.0% year-over-year.
- Ranks #146 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.226 | -60.0% |
| FY2024 | $5.563 | +2.5% |
| FY2023 | $5.425 | -13.5% |
| FY2022 | $6.274 | -17.8% |
| FY2021 | $7.635 | -33.7% |
| FY2020 | $11.51 | +120.7% |
| FY2019 | $5.216 | +14.0% |
| FY2018 | $4.575 | +33.1% |
| FY2017 | $3.437 | +13.0% |
| FY2016 | $3.041 | -63.2% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026